JP2005521651A5 - - Google Patents

Download PDF

Info

Publication number
JP2005521651A5
JP2005521651A5 JP2003560008A JP2003560008A JP2005521651A5 JP 2005521651 A5 JP2005521651 A5 JP 2005521651A5 JP 2003560008 A JP2003560008 A JP 2003560008A JP 2003560008 A JP2003560008 A JP 2003560008A JP 2005521651 A5 JP2005521651 A5 JP 2005521651A5
Authority
JP
Japan
Prior art keywords
ethyl
carbazol
carboxamide
oxopyrrolidine
rac
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003560008A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005521651A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CH2002/000725 external-priority patent/WO2003059905A1/de
Publication of JP2005521651A publication Critical patent/JP2005521651A/ja
Publication of JP2005521651A5 publication Critical patent/JP2005521651A5/ja
Pending legal-status Critical Current

Links

JP2003560008A 2001-12-31 2002-12-27 ピロリドンカルボキサミド類 Pending JP2005521651A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH23812001 2001-12-31
CH0200429 2002-08-05
PCT/CH2002/000725 WO2003059905A1 (de) 2001-12-31 2002-12-27 Pyrrolidon-carboxamide

Publications (2)

Publication Number Publication Date
JP2005521651A JP2005521651A (ja) 2005-07-21
JP2005521651A5 true JP2005521651A5 (cg-RX-API-DMAC7.html) 2009-11-26

Family

ID=25705687

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003560008A Pending JP2005521651A (ja) 2001-12-31 2002-12-27 ピロリドンカルボキサミド類

Country Status (8)

Country Link
EP (1) EP1463724A1 (cg-RX-API-DMAC7.html)
JP (1) JP2005521651A (cg-RX-API-DMAC7.html)
KR (1) KR20040072697A (cg-RX-API-DMAC7.html)
CN (1) CN100534990C (cg-RX-API-DMAC7.html)
AU (1) AU2002350366A1 (cg-RX-API-DMAC7.html)
CA (1) CA2471620A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA04006458A (cg-RX-API-DMAC7.html)
WO (1) WO2003059905A1 (cg-RX-API-DMAC7.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0319151D0 (en) * 2003-08-14 2003-09-17 Glaxo Group Ltd Novel compounds
US20080125403A1 (en) 2004-04-02 2008-05-29 Merck & Co., Inc. Method of Treating Men with Metabolic and Anthropometric Disorders
US7880001B2 (en) 2004-04-29 2011-02-01 Abbott Laboratories Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
US8415354B2 (en) 2004-04-29 2013-04-09 Abbott Laboratories Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
US20100222316A1 (en) 2004-04-29 2010-09-02 Abbott Laboratories Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
US20090192198A1 (en) 2005-01-05 2009-07-30 Abbott Laboratories Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
US8198331B2 (en) 2005-01-05 2012-06-12 Abbott Laboratories Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
KR101496190B1 (ko) 2005-01-05 2015-02-26 애브비 인코포레이티드 11-베타-하이드록시스테로이드 데하이드로게나제 타입 1 효소의 억제제로서의 아다만틸 유도체
EP1864971A4 (en) * 2005-03-31 2010-02-10 Takeda Pharmaceutical PROPHYLACTIC / THERAPEUTIC AGENT AGAINST DIABETES
JP4726243B2 (ja) * 2005-08-09 2011-07-20 第一三共株式会社 新規セルコスポラミド誘導体
JP4085129B2 (ja) * 2005-08-09 2008-05-14 第一三共株式会社 新規セルコスポラミド誘導体
US7435833B2 (en) 2006-04-07 2008-10-14 Abbott Laboratories Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
JP5736098B2 (ja) 2007-08-21 2015-06-17 アッヴィ・インコーポレイテッド 中枢神経系障害を治療するための医薬組成物
GB0815781D0 (en) * 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
US8293925B2 (en) 2009-09-21 2012-10-23 Chemocentryx, Inc. Pyrrolidinone carboxamide derivatives
CN102827056B (zh) * 2012-09-03 2014-07-23 华东理工大学 N-芳基取代吡咯烷酮衍生物及其用途
RU2016143092A (ru) * 2014-04-04 2018-05-08 Санофи Замещенные соединения инданона в качестве модуляторов gpr119 для лечения диабета, ожирения, дислипидемии и связанных с ними нарушений
US10968176B2 (en) 2014-09-14 2021-04-06 Nanosynthons Llc Pyrrolidone derivatives, oligomers and polymers
EP3194365A4 (en) * 2014-09-14 2018-04-25 Nanosynthons LLC Pyrrolidone derivatives, oligomers and polymers

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB856452A (en) * 1957-06-27 1960-12-14 Bayer Ag Protective agents against textile pests, mould and bacteria
US5281612A (en) * 1982-09-09 1994-01-25 Warner-Lambert Company Naphthyridine antibacterial agents
DK0393607T3 (da) * 1989-04-19 1996-03-18 Otsuka Pharma Co Ltd Phenylcarboxylsyrederivater med en heteroring
US6387932B1 (en) * 1999-06-25 2002-05-14 Merck & Co., Inc. Somatostatin agonists
WO2001007409A1 (en) * 1999-07-23 2001-02-01 Astrazeneca Uk Limited Carbazole derivatives and their use as neuropeptide y5 receptor ligands
GB0010757D0 (en) * 2000-05-05 2000-06-28 Astrazeneca Ab Chemical compounds

Similar Documents

Publication Publication Date Title
TW386081B (en) Opioid compounds
US6930185B2 (en) Melanin-concentrating hormone antagonist
JP3664492B2 (ja) タチキニン nk▲下3▼ 受容体アンタゴニストとしてのキノリン誘導体
CN1189170C (zh) 噻吩基唑基烷氧基乙胺,它们的制备以及它们作为药物的应用
CN1671377A (zh) 作为大麻素-cb1受体配体的1h-1,2,4-三唑-3-酰胺衍生物
JP2005508867A (ja) Hivプロテアーゼ阻害剤、それらを含有する組成物、それらの薬学的使用およびそれらの合成用材料
KR20030009376A (ko) 3-(디아릴메틸렌)-8-아자비사이클로[3.2.1]옥탄 유도체
EP1447402A1 (en) Quinoline compound
JP2000504677A (ja) 5ht7レセプター・アンタゴニスト用のスルホンアミド誘導体
JPH07503247A (ja) オピオイドジアリールメチルピペラジンおよびピペリジン
CA2386517A1 (en) Amine derivatives
JP4056977B2 (ja) 睡眠障害治療薬
SK280906B6 (sk) Použitie tetrahydrokarbazolových derivátov
CS228532B2 (en) Production method of phenylpiperazine derivative
JPH11505237A (ja) ジアリールジアミン誘導体およびそれらのデルタオピオイド(アント)−アゴニストとしての使用
MXPA04002338A (es) Derivados de carbazol y su uso como antagonistas receptores del npy5.
JP4874107B2 (ja) Hiv及び炎症の治療のためのccr5受容体拮抗活性を有するイミダゾピリジン置換トロパン誘導体
BRPI0413393A (pt) fexofenadina, composição farmaceuticamente aceitável, método de tratamento antihistamìnico, composição, processo para preparar fexofenadina e uso de fexofenadina
JP2005500370A5 (cg-RX-API-DMAC7.html)
CN100471844C (zh) 4-(苯基-哌嗪基-甲基)苯甲酰胺衍生物及其在治疗疼痛或胃肠疾病中的用途
CN1516684A (zh) 氘代的N-和α-取代的二苯基烷氧基乙酸氨基烷基酯以及含该化合物的药物
CA2438854A1 (en) Method of preparing non-hydrated fexofenadine hydrochloride and novel crystalline form obtainable by this method
JP2011528030A5 (cg-RX-API-DMAC7.html)
CN1043574C (zh) 具有中枢神经系统活性的杂环胺
EP2060563A1 (en) Cyclic aminoalkylcarboxamide derivative